Tag: Food and Drug Administration
More Executive Orders Will Not Fix Healthcare

Draconian measures to “flatten the curve” were implemented to prevent the healthcare sector from becoming overwhelmed with infected patients. Now, as many states reopen for business, it seems relatively few healthcare facilities are overwhelmed. However, much of the healthcare industry is still struggling. Becker Hospital Review finds that more than 250 hospitals are furloughing…
Read More »

The Mask Madness of Big Government

As Newsweek reports, people are sewing their own face masks to protect themselves against the coronavirus. Readers might wonder why something as simple as a face mask might be in short supply. As it turns out, such masks are strictly regulated. The federal Food and Drug Administration (FDA) and Centers for Disease Control and…
Read More »

FDA Acknowledges Coronavirus Is Causing More Drug Shortages

The first outbreak of the coronavirus occurred in China nearly two months ago. The disease quickly spread through the country. As of March 5th, the coronavirus is responsible for over 80,000 confirmed cases and nearly 3,400 deaths across China. Globally over 98,000 people are infected, resulting in nearly 4,000 deaths. At this time, the…
Read More »

FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices

In 2015, Turning Pharmaceuticals CEO Martin Shkreli increased the price of the drug Daraprim nearly 5,000 percent from $13.50 to $750 per pill. The price hike generated widespread outrage, earning Shkreli the moniker “Pharma Boy” and the designation, “pharmaceutical greed villain.” Daraprim became “the poster child for the issue of high drug prices.”

FDA Expands Ecstasy Access to Veterans with PTSD

In 2006, Johnathan Lubecky was deployed to Iraq. While fighting for his country, Johnathan faced constant enemy strikes, one of which resulted in a traumatic brain injury. Exposures to the horrors of war resulted in Johnathan developing post-traumatic stress disorder (PTSD).

Will FDA Approve Biogen’s Promising New Treatment for Alzheimer’s?

We’re only a few weeks into the new year, and the Food and Drug Administration will soon make a decision that will affect pharmaceutical regulation for decades. Last year, after failing an FDA-required futility test, Biogen abandoned its efforts to develop an Alzheimer’s treatment named aducanumab. However, after conducting an analysis using an expanded…
Read More »

New FDA Commissioner, Same FDA Problem

President Trump has nominated (and fired) numerous individuals to governmental positions while in office. Arguably, his most popular nominee was Food and Drug Administration Commissioner Scott Gottlieb. As a Modern Healthcare article notes, “Dr. Scott Gottlieb accomplished a rare feat during his two-year tenure as head of the Food and Drug Administration—he earned praise…
Read More »

Telemedicine Continues to Reach New Heights

Imagine you suddenly became injured and needed medical help quickly. How long would it take you to see a physician? For an increasing number of Americans, the answer may be concerning. According to a recent survey of 15 major metropolitan areas, wait times to see a physician for new patients increased by about 30…
Read More »

FDA Investigates Supposed Link Between Vaping and Seizures

Although the FDA acknowledges it has yet to find a causal relationship between vaping and seizures, it may continue and strengthen its “historic crackdown” of the vaping industry.

San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke

Will the ban work? Unfortunately, governmental efforts to reduce or eliminate vices are often spectacular failures.

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org